TCTMD20h
Rivaroxaban Doesn’t Cut Cognitive Decline, Stroke, or TIA in Younger AF Patients
CHICAGO, IL—Giving rivaroxaban (Xarelto; Bayer/Janssen) to adults under the age of 65, after an atrial fibrillation (AF) ...
TCTMD1h
First-line Catheter Ablation Works for Post-MI VT Suppression: VANISH2
Clinicians typically first turn to antiarrhythmic drugs, but switching up the order may be offer patients better outcomes.
TCTMD20h
SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity
CHICAGO, IL—The weight-loss medication tirzepatide (Eli Lilly) significantly cut the risk of cardiovascular mortality and ...
TCTMD6h
Intensive BP Lowering in Diabetes Reduces CV Events: BPROAD
Amidst discrepant SPRINT and ACCORD data, this study confirms the benefits seen in nondiabetics, Shawna Nesbitt says.